GLP-1 Market
LLY $1279.14 ▲ +0.4% NVO $39.13 ▲ +0.2% PFE $29.79 ▼ -0.8% VKTX $24.21 ▼ -0.8% KLRA $12.77 ▼ -0.6% GPCR $21.10 ▼ -0.4% RHHBY $59.98 ▼ -1.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Immunosuppressive Agents

Company
City of Hope Medical Center
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
61 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

61 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 27, 2026

Find a Clinical Trial Near Me

See recruiting studies for Immunosuppressive Agents and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00001352

    Fungal Infection Susceptibility

    National Institute of Allergy and Infectious Diseases (NIAID) 800 participants 1 site
    Other conditions: Cryptococcal Infection, Cryptococcal Pneumonia, Pulmonary Cryptococcosis, Cryptococcal Meningitis, Cryptococcosis
    View official trial listing →
  • Recruiting NCT NCT01283295

    Immune Monitoring and Assay Development in Organ Transplant Recipients

    Emory University 5000 participants Est. completion 2028-12 2 sites
    Other conditions: Organ Transplantation, Transplantation Immunology
    View official trial listing →
  • Recruiting NCT NCT01555892

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

    Not yet reported Baylor College of Medicine 136 participants Est. completion 2027-07-01 3 sites
    Other conditions: Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease, Lymphoma
    View official trial listing →
  • Recruiting NCT NCT02446431

    Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

    Not yet reported Miller Children's & Women's Hospital Long Beach 20 participants Est. completion 2029-07 2 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT03092180

    Optimizing Treatment on Idiopathic Inflammatory Myopathies

    University of Sao Paulo 60 participants Est. completion 2024-12-04 1 site
    Other conditions: Idiopathic Inflammatory Myopathies
    View official trial listing →
  • Recruiting NCT NCT03852407

    Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

    Not yet reported University of Liege 114 participants Est. completion 2038-11-01 10 sites
    Other conditions: Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes, Chronic Myeloid Leukemia in Remission, Myeloproliferative Syndrome, Myeloproliferative Disorder, Acute Lymphoid Leukemia in Remission, Multiple Myeloma, Chronic Lymphoid Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04180085

    Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)

    Not yet reported Nantes University Hospital 25 participants Est. completion 2028-01-01 4 sites
    Other conditions: Heart Transplant Failure
    View official trial listing →
  • Recruiting NCT NCT04182984

    TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study

    Tang-Du Hospital 200 participants Est. completion 2026-06-30 1 site
    Other conditions: Ocular Myasthenia Gravis
    View official trial listing →
  • Recruiting NCT NCT04207580

    A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.

    University Hospital, Limoges 1180 participants Est. completion 2048-01 48 sites
    Other conditions: Idiopathic Nephrotic Syndrome
    View official trial listing →
  • Recruiting NCT NCT04474847

    Abatacept for the Treatment of Giant Cell Arteritis

    Not yet reported University of Pennsylvania 78 participants Est. completion 2029-12 10 sites
    Other conditions: Giant Cell Arteritis
    View official trial listing →
  • Recruiting NCT NCT04521790

    Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

    Scientific Institute San Raffaele 1000 participants Est. completion 2035-12-31 1 site
    Other conditions: Myocarditis, Ventricular Arrythmia, Inflammatory Cardiomyopathy, Genetic Predisposition, Autoimmunity, Arrhythmia, Cardiomyopathies, Immunosuppression, Catheter Ablation
    View official trial listing →
  • Recruiting NCT NCT04625907

    FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

    Not yet reported, Not yet reported University of Birmingham 1672 participants Est. completion 2030-06 128 sites
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT04702022

    Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients

    Not yet reported University of Liege 50 participants Est. completion 2027-01-01 1 site
    Other conditions: Kidney Transplant Rejection, Kidney Transplant; Complications
    View official trial listing →
  • Recruiting NCT NCT04745728

    Different Immunosuppressive Treatment in iMN

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2029-12 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04972760

    Baricitinib in Patients With Relapsing or naïve Dermatomyositis

    Not yet reported Assistance Publique - Hôpitaux de Paris 62 participants Est. completion 2028-02-28 1 site
    Other conditions: Dermatomyositis
    View official trial listing →
  • Recruiting NCT NCT05305066

    Stand UP to Rheumatoid Arthritis (SUPRA)

    Not yet reported Marie Hudson, MD 75 participants Est. completion 2030-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT05321758

    Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease

    Not yet reported Tongji Hospital 50 participants Est. completion 2027-06-30 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Recruiting NCT NCT05415267

    Immunosuppression and COVID-19 Boosters

    Not yet reported Kirby Institute 320 participants Est. completion 2026-12-31 5 sites
    Other conditions: COVID-19
    View official trial listing →
  • Recruiting NCT NCT05436418

    The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

    Not yet reported, Not yet reported National Cancer Institute (NCI) 260 participants Est. completion 2028-06-25 2 sites
    Other conditions: Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05463133

    Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2032-12-31 1 site
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Recruiting NCT NCT05860400

    Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

    Peking Union Medical College Hospital 39 participants Est. completion 2026-09 1 site
    Cardiovascular disease Other conditions: Coronary Artery Stenosis, Coronary Artery Restenosis, Inflammation, Inflammatory Disease, Inflammation Vascular
    View official trial listing →
  • Recruiting NCT NCT06047171

    Rescue of Nephrons With ALE.F02 (RENAL-F02)

    Not yet reported Alentis Therapeutics AG 80 participants Est. completion 2028-02-28 53 sites Stand-alone
    Other conditions: Glomerulonephritis Rapidly Progressive
    View official trial listing →
  • Recruiting NCT NCT06213857

    Beneficial Effect of Silymarin in Ulcerative Colitis

    Not yet reported Tanta University 44 participants Est. completion 2025-06 2 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Recruiting NCT NCT06254248

    Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma

    Not yet reported Assistance Publique - Hôpitaux de Paris 50 participants Est. completion 2030-01-01 10 sites
    Other conditions: Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic Treatment
    View official trial listing →
  • Recruiting NCT NCT06262776

    Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

    Not yet reported Central Adelaide Local Health Network Incorporated 160 participants Est. completion 2027-12 1 site
    Other conditions: Immunosuppression, Vaccine Response Impaired
    View official trial listing →
  • Recruiting NCT NCT06268769

    Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs

    Not yet reported Edward Geissler 300 participants Est. completion 2029-09 9 sites
    Other conditions: Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT06363006

    Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

    Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2027-01-01 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06371274

    A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

    Not yet reported First Affiliated Hospital of Zhejiang University 29 participants Est. completion 2026-04-30 1 site
    Other conditions: Triple-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06472219

    PREDICATE Trial For Respiratory Tract Infections

    Not yet reported The University of Hong Kong 1300 participants Est. completion 2028-12-08 1 site
    Other conditions: Respiratory Tract Infections
    View official trial listing →
  • Recruiting NCT NCT06479603

    RCT of Nintedanib in Fibrotic Sarcoidosis

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 120 participants Est. completion 2026-01-31 1 site
    Other conditions: Sarcoidosis, Pulmonary
    View official trial listing →
  • Recruiting NCT NCT06594068

    Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

    Not yet reported AstraZeneca 16 participants Est. completion 2027-08-31 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT06652126

    Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria

    University Hospital, Lille 1000 participants Est. completion 2029-12-01 1 site
    Other conditions: Critically-ill Patients
    View official trial listing →
  • Recruiting NCT NCT06682169

    Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 182 participants Est. completion 2030-12 41 sites
    Other conditions: Graft-versus-host Disease
    View official trial listing →
  • Recruiting NCT NCT06695741

    Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 75 participants Est. completion 2027-06-30 1 site
    Other conditions: Severe Aplastic Anemia, Cyclophosphamide Reduced-dose, Immunosuppressive Therapy
    View official trial listing →
  • Recruiting NCT NCT06750172

    Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method

    Peking Union Medical College Hospital 33 participants Est. completion 2024-12-25 1 site
    Other conditions: Primary Aldosteronism
    View official trial listing →
  • Recruiting NCT NCT06821919

    Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)

    Western Galilee Hospital-Nahariya 70 participants Est. completion 2031-12-30 1 site
    Other conditions: Diabetes Mellitus, Kidney Disease
    View official trial listing →
  • Recruiting NCT NCT06824714

    Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation System

    Nanjing Medical University 150 participants Est. completion 2028-07-01 1 site
    Other conditions: Large Vessel Vasculitis
    View official trial listing →
  • Recruiting NCT NCT06859424

    A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

    Not yet reported Center for International Blood and Marrow Transplant Research 358 participants Est. completion 2028-06 13 sites Stand-alone
    Other conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06873100

    Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

    Not yet reported, Not yet reported Peking University People's Hospital 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Relapsing Polychondritis
    View official trial listing →
  • Recruiting NCT NCT06881927

    Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

    Not yet reported University Hospital, Strasbourg, France 212 participants Est. completion 2029-08-01 1 site
    Other conditions: Sepsis and Septic Shock, Acute Respiratory Failure, Kidney Transplant Recipients, Immunosuppressive Agents
    View official trial listing →
  • Recruiting NCT NCT06885957

    Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD

    Tongji Hospital 200 participants Est. completion 2027-12-31 1 site
    Other conditions: NMO Spectrum Disorder
    View official trial listing →
  • Recruiting NCT NCT06962800

    A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

    Not yet reported Biogen 180 participants Est. completion 2031-01-17 114 sites
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT06981767

    Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus

    Not yet reported Cairo University 42 participants Est. completion 2026-08-15 1 site
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Recruiting NCT NCT07021495

    SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

    Leiden University Medical Center 840 participants Est. completion 2029-12-31 8 sites
    Other conditions: Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO), Atopic Dermatitis (AD), CTCL/ Mycosis Fungoides
    View official trial listing →
  • Recruiting NCT NCT07045467

    Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study

    Not yet reported Qianfoshan Hospital 30 participants Est. completion 2027-06-01 1 site
    Chronic kidney disease Other conditions: Renal Transplantation
    View official trial listing →
  • Recruiting NCT NCT07077486

    Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

    Not yet reported Tongji Hospital 100 participants Est. completion 2027-03-25 1 site
    Other conditions: Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT07084480

    Giant Cell Arteritis - Ways to Precision Medicine

    Wuerzburg University Hospital 400 participants Est. completion 2033-07-31 1 site
    Other conditions: Giant Cell Arteritis, Polymyalgia Rheumatic (PMR)
    View official trial listing →
  • Recruiting NCT NCT07104058

    A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD

    Not yet reported Luo Yaping 46 participants Est. completion 2027-12-01 1 site
    Other conditions: IgG4-Related Diseases
    View official trial listing →
  • Recruiting NCT NCT07120464

    Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

    Liaoning Chengda Biotechnology CO., LTD 180 participants Est. completion 2026-12-31 1 site
    Other conditions: Rabies Exposure, Immunocompromised, Chronic Disease
    View official trial listing →
  • Recruiting NCT NCT07173114

    New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)

    University Hospital, Montpellier 300 participants Est. completion 2026-09-22 2 sites
    Other conditions: Hospitalization, All Conditions
    View official trial listing →
  • Recruiting NCT NCT07242092

    Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs

    Not yet reported University of Sao Paulo General Hospital 192 participants Est. completion 2028-12-30 1 site
    Other conditions: Autoimmune Rheumatic Diseases
    View official trial listing →
  • Recruiting NCT NCT07319598

    A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease

    Not yet reported Peking University Third Hospital 100 participants Est. completion 2027-01-01 1 site
    Other conditions: Interstitial Lung Disease (ILD), Connective Tissue Disease-associated Interstitial Lung Disease
    View official trial listing →
  • Recruiting NCT NCT07340463

    The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

    Not yet reported Nanjing University School of Medicine 50 participants Est. completion 2029-06 1 site
    Other conditions: Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
    View official trial listing →
  • Recruiting NCT NCT07410039

    Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

    Not yet reported Chinese PLA General Hospital 200 participants Est. completion 2029-06-30 1 site
    Other conditions: Neuromyelitis Optica Spectrum Disorder Attack
    View official trial listing →
  • Recruiting NCT NCT07430306

    A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

    Not yet reported AstraZeneca 245 participants Est. completion 2029-01-26 107 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT07493395

    Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

    Not yet reported University Hospital, Montpellier 6 participants Est. completion 2028-06-11 4 sites
    Other conditions: Scleroderma, Systemic
    View official trial listing →
  • Recruiting NCT NCT07505199

    Safety and Efficacy of FAP iCDC in Ischemic Cardiomyopathy

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2029-04-01 1 site
    Other conditions: Ischemic Cardiomyopathy, Cell Therapy
    View official trial listing →
  • Recruiting NCT NCT07581704

    Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

    Not yet reported Christopher Strouse 10 participants Est. completion 2029-10-01 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT07679412

    Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.

    Not yet reported LucasBio 5 participants Est. completion 2027-08-14 1 site
    Other conditions: CMV Retinitis
    View official trial listing →
  • Recruiting NCT NCT07815834

    FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)

    Not yet reported Fudan University 198 participants Est. completion 2031-03-01 1 site
    Other conditions: Colon Rectal Cancer Adenocarcinoma, Peritoneal (Metastatic) Cancer, Second-line Treatment, Radiation Therapy, Immunotherapy
    View official trial listing →
  • Recruiting NCT NCT07895394

    Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients

    Not yet reported Seoul National University Hospital 80 participants Est. completion 2028-10 1 site
    Other conditions: Vaccination, Respiratory Syncytial Virus (RSV), Lung Transplant Recipient
    View official trial listing →
  • Completed NCT NCT00001637

    Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 28 participants Est. completion 2016-12-28 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Graft vs Host Disease, Leukemia, Myelodysplastic Syndrome, Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00001764

    Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2004-06 1 site
    Other conditions: Vasculitis, Wegener's Granulomatosis
    View official trial listing →
  • Completed NCT NCT00001839

    A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

    Not yet reported National Institutes of Health Clinical Center (CC) 182 participants Est. completion 2000-05 1 site
    Other conditions: Hematologic Diseases, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00016419

    S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

    Not yet reported SWOG Cancer Research Network 130 participants Est. completion 2007-01 94 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00021645

    Vitamin E to Treat Uveitis-Associated Macular Edema

    Not yet reported National Eye Institute (NEI) 80 participants Est. completion 2004-06 1 site
    Other conditions: Cystoid Macular Edema, Uveitis
    View official trial listing →
  • Terminated NCT NCT00023244

    Steroid Withdrawal in Pediatric Kidney Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 274 participants Est. completion 2005-06 19 sites
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00033475

    Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation

    Not yet reported University of Edinburgh 50 participants 12 sites
    Other conditions: Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT00056355

    Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2005-11 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT00061360

    Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 77 participants Est. completion 2015-09-08 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00080431

    Daclizumab to Treat HIV-Infected Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2007-12-28 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Terminated NCT NCT00104338

    Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy

    Not yet reported Astellas Pharma Inc 45 participants Est. completion 2006-08 21 sites
    Other conditions: BK Polyomavirus, Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00104858

    Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet reported Fred Hutchinson Cancer Center 66 participants Est. completion 2018-03-30 5 sites
    Other conditions: Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage III Small Lymphocytic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Small Lymphocytic Lymphoma, T-Cell Large Granular Lymphocyte Leukemia
    View official trial listing →
  • Completed NCT NCT00116090

    Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

    National Eye Institute (NEI) 6300 participants Est. completion 2008-04-21 4 sites
    Other conditions: Uveitis, Cancer, Infection, Mortality, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00125307

    Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

    Not yet reported Chinese University of Hong Kong 20 participants Est. completion 2008-02 1 site
    Other conditions: Lupus Nephritis, Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00149916

    Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107

    Not yet reported Novartis Pharmaceuticals 139 participants
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00150891

    Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection

    University of Giessen 84 participants Est. completion 2006-01 1 site
    Other conditions: Renal Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00154232

    Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

    Not yet reported Novartis Pharmaceuticals 46 participants
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00154297

    Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

    Not yet reported Novartis Pharmaceuticals 139 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00154310

    Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

    Not yet reported Novartis 300 participants Est. completion 2008-09 3 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT00160732

    Allogenic Islet Cell Transplantation

    Not yet reported, Not yet reported University of Chicago 50 participants Est. completion 2030-10 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00160966

    Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

    Not yet reported University of Giessen 108 participants Est. completion 2010-03 1 site
    Other conditions: Polyomavirus Infections
    View official trial listing →
  • Status unknown NCT NCT00166816

    The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients

    Not yet reported National Taiwan University Hospital 40 participants Est. completion 2003-06 1 site
    Other conditions: Transplantation, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00171509

    Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients

    Not yet reported Novartis 61 participants Est. completion 2005-10
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT00189787

    Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

    Not yet reported Astellas Pharma Inc 370 participants Est. completion 2005-08 49 sites
    Other conditions: Asthma, Bronchial, Bronchial Asthma
    View official trial listing →
  • Completed NCT NCT00193648

    Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

    Not yet reported Northwell Health 21 participants Est. completion 2007-10 2 sites
    Other conditions: Focal Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00195988

    Comparison of Immunosuppression Protocols After LTx in Children

    Not yet reported Children's Memorial Health Institute, Poland 40 participants Est. completion 2006-07 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00198224

    Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients

    Not yet reported Indiana University 50 participants Est. completion 2005-05 2 sites
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT00223054

    Polymorphism of the Cytochrome P450-system in Renal Transplants

    University Hospital Schleswig-Holstein 200 participants Est. completion 2006-10 1 site
    Other conditions: Function of Renal Transplant
    View official trial listing →
  • Terminated NCT NCT00235781

    Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

    Not yet reported Washington University School of Medicine 90 participants Est. completion 2006-02 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00240955

    Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

    Not yet reported Novartis 79 participants Est. completion 2006-05
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT00252655

    Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients

    Not yet reported Wayne State University 40 participants Est. completion 2009-06 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00260208

    Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

    Not yet reported Novartis Pharmaceuticals 361 participants 2 sites
    Other conditions: Liver Transplant, Hepatitis C
    View official trial listing →
  • Completed NCT NCT00260689

    Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 136 participants Est. completion 2016-05-04 1 site
    Other conditions: Immunosuppresion, Thrombocytopenia, Pancytopenia, Neutropenia
    View official trial listing →
  • Completed NCT NCT00275522

    The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

    Not yet reported Mayo Clinic 16 participants Est. completion 2007-12 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00276250

    Islet Transplantation Using Abatacept

    Not yet reported Emory University 5 participants Est. completion 2014-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00307593

    RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides

    Not yet reported Assistance Publique - Hôpitaux de Paris 20 participants Est. completion 2007-06 1 site
    Other conditions: Wegener's Granulomatosis, Churg-Strauss Syndrome, Microscopic Polyangiitis
    View official trial listing →
  • Terminated NCT NCT00307658

    Intravenous Immunoglobulin After Relapse in Vasculitis

    Not yet reported Assistance Publique - Hôpitaux de Paris 40 participants Est. completion 2006-07 2 sites
    Other conditions: ANCA + Vasculitides Relapsing Either Under Corticosteroid, and Immunosuppressant Therapies or After One Year, Post Treatment.
    View official trial listing →
  • Terminated NCT NCT00346151

    Belatacept to Prevent Organ Rejection in Kidney Transplant Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2010-02 2 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Terminated NCT NCT00354198

    Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis

    Not yet reported National Taiwan University Hospital 7 participants Est. completion 2010-06 1 site
    Other conditions: Glomerulonephritis
    View official trial listing →
  • Terminated NCT NCT00365274

    SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 6 participants Est. completion 2010-05 1 site
    Other conditions: Anaplastic Large Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00365521

    Prophylactic Photodynamic Therapy to Organ Transplant Patients

    Not yet reported Bispebjerg Hospital 50 participants 1 site
    Other conditions: Organ Transplants
    View official trial listing →
  • Completed NCT NCT00365846

    "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

    Not yet reported University of Wisconsin, Madison 29 participants Est. completion 2006-07 1 site
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00377962

    Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

    Not yet reported Novartis Pharmaceuticals 282 participants Est. completion 2010-02 6 sites
    Other conditions: Disorder Related to Cardiac Transplantation
    View official trial listing →
  • Completed NCT NCT00384137

    A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

    Not yet reported Astellas Pharma Inc 128 participants Est. completion 2007-07 13 sites
    Other conditions: Transplantation
    View official trial listing →
  • Status unknown NCT NCT00399971

    Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia

    Not yet reported, Not yet reported Shenzhen Zhongxing Yangfan Biotech Co. Ltd. 100 participants Est. completion 2009-12 1 site
    Other conditions: Anemia, Aplastic
    View official trial listing →
  • Completed NCT NCT00400400

    Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance

    Not yet reported Novartis Pharmaceuticals 400 participants 53 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00402168

    A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids

    Not yet reported Bristol-Myers Squibb 173 participants Est. completion 2013-06 44 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00404794

    A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis

    Not yet reported Hospital Authority, Hong Kong 20 participants Est. completion 2009-10 1 site
    Other conditions: Lupus Nephritis, Glomerulonephritis, Membranous
    View official trial listing →
  • Status unknown NCT NCT00426049

    Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

    Not yet reported German Heart Institute 484 participants 1 site
    Cardiovascular disease Other conditions: Coronary Restenosis
    View official trial listing →
  • Completed NCT NCT00434811

    Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2014-05 8 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00434850

    Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 14 participants Est. completion 2013-11 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00446264

    Islet Allotransplantation With Steroid Free Immunosuppression

    Not yet reported University Hospital, Lille 14 participants Est. completion 2009-02 1 site
    Other conditions: Type 1 Diabetes, Hypoglycemia, Metabolic Diseases
    View official trial listing →
  • Terminated NCT NCT00447265

    Etanercept for the Treatment of Lupus Nephritis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 1 participants Est. completion 2009-03 6 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00468403

    LEA29Y (Belatacept) Emory Edmonton Protocol

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2013-04 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00489203

    Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 140 participants 2 sites
    Obstructive sleep apnea Other conditions: Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Graft Versus Host Disease, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Disease, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00494741

    MMF vs. AZA for Kidney Transplantation

    Not yet reported Mario Negri Institute for Pharmacological Research 233 participants Est. completion 2017-11-29 6 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Withdrawn NCT NCT00514982

    Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2011-03-08 1 site
    Other conditions: Hermanski-Pudlak Syndrome, Colitis, Cytokines, Lymphocytes, Drug Evaluation
    View official trial listing →
  • Completed NCT NCT00531063

    This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

    Not yet reported Novartis Pharmaceuticals 237 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00542776

    Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

    Boston Children's Hospital 146 participants Est. completion 2008-02 1 site
    Other conditions: Inflammatory Bowel Disease (IBD), Immunosuppressed or Non-Immunosuppressed, Influenza Vaccine, Antibody Titers, Seroprotective Titers
    View official trial listing →
  • Completed NCT NCT00554502

    Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy

    Not yet reported RWTH Aachen University 148 participants Est. completion 2015-02 34 sites
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT00556933

    Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

    Not yet reported University of Nebraska 180 participants Est. completion 2011-06-01 1 site
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT00582738

    Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

    Not yet reported Novartis Pharmaceuticals 43 participants Est. completion 2010-01 1 site
    Other conditions: Recurrent Hepatitis C
    View official trial listing →
  • Completed NCT NCT00611351

    Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

    Not yet reported University of Nebraska 5 participants Est. completion 2008-09-17 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Secondary Myelofibrosis
    View official trial listing →
  • Terminated NCT NCT00646425

    The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis

    Not yet reported Cerimon Pharmaceuticals 5 participants Est. completion 2008-11 6 sites
    Other conditions: Non-infectious Uveitis
    View official trial listing →
  • Status unknown NCT NCT00647283

    Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance

    Not yet reported Hospital Clinic of Barcelona 80 participants Est. completion 2012-12 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00683046

    T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

    Not yet reported University of Chicago 204 participants Est. completion 2014-12 1 site
    Other conditions: Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia, Malignant Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia, Myeloproliferative Disorder, Anemia, Aplastic, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00686556

    Total Marrow Irradiation for Refractory Acute Leukemia

    Not yet reported Masonic Cancer Center, University of Minnesota 12 participants Est. completion 2016-12 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT00694408

    A Pilot Trial of Pediatric Liver Transplantation Without Steroids

    Not yet reported Birmingham Women's and Children's NHS Foundation Trust 15 participants Est. completion 2011-08 1 site
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00705484

    European Safety Registry in Ulcerative Colitis (P04808)

    Merck Sharp & Dohme LLC 2239 participants Est. completion 2016-10-20
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00709722

    Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

    Not yet reported, Not yet reported Nippon Kayaku Co., Ltd. 21 participants Est. completion 2007-04 6 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00717678

    A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 73 participants Est. completion 2010-04 5 sites
    Other conditions: Kidney Transplantation, Transplantation Immunology, Host vs Graft Reaction
    View official trial listing →
  • Completed NCT NCT00720408

    A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

    Not yet reported Astellas Pharma Inc 48 participants Est. completion 2009-09 4 sites
    Other conditions: Liver Transplantation, Transplantation Immunology, Host vs Graft Reaction
    View official trial listing →
  • Terminated NCT NCT00722280

    Human Upper Extremity (Hand and Forearm) Allotransplantation

    Not yet reported University of Pittsburgh 38 participants Est. completion 2017-10 1 site
    Other conditions: Amputation, Traumatic
    View official trial listing →
  • Terminated NCT NCT00727194

    Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

    Not yet reported Alexion Pharmaceuticals, Inc. 14 participants Est. completion 2011-07 25 sites
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Completed NCT NCT00729248

    The Differential Effects of 3 Different Immunosuppressive

    Northwestern University 12 participants Est. completion 2010-01 1 site
    Other conditions: Immunosuppression, Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00729768

    A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation

    Not yet reported, Not yet reported Genentech, Inc.
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00733733

    Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor

    Not yet reported Radboud University Medical Center 180 participants Est. completion 2010-06 1 site
    Other conditions: Renal Transplant Patients, Recipients of a Kidney From a Non-Heart-Beating Donor
    View official trial listing →
  • Completed NCT NCT00738257

    A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.

    Not yet reported Novartis Pharmaceuticals 126 participants 1 site
    Other conditions: Bone Loss
    View official trial listing →
  • Completed NCT NCT00787722

    Hematopoietic Stem Cell Transplant in Devic's Disease

    Not yet reported, Not yet reported Northwestern University 13 participants Est. completion 2018-11 1 site
    Other conditions: Devic's Disease
    View official trial listing →
  • Completed NCT NCT00788567

    CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants

    Not yet reported Hoffmann-La Roche 136 participants Est. completion 2008-05 9 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00795132

    Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

    Not yet reported University of Utah 47 participants Est. completion 2009-07 1 site
    Other conditions: Acute Leukaemia, Chronic Disease, Leukemia, Myelodysplasia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00805571

    Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

    Northwell Health 120 participants 1 site
    Other conditions: Kidney Transplant Dysfunction
    View official trial listing →
  • Completed NCT NCT00812123

    Calcineurin Free Immunosuppression in Renal Transplant Recipients

    Not yet reported University Hospital, Basel, Switzerland 127 participants Est. completion 2005-07 1 site
    Chronic kidney disease Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00816504

    Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5

    Not yet reported Northwell Health Est. completion 2009-12 1 site
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00829595

    Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

    Not yet reported Cedars-Sinai Medical Center 69 participants Est. completion 2007-12 1 site
    Other conditions: Inflammatory Bowel Disease, Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT00856505

    Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation

    Not yet reported, Not yet reported University Hospital Freiburg 38 participants Est. completion 2011-03 1 site
    Other conditions: Hematologic Diseases
    View official trial listing →
  • Status unknown NCT NCT00895739

    Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

    Not yet reported Federico II University 50 participants 1 site
    Other conditions: Nonmalignant Neoplasm
    View official trial listing →
  • Completed NCT NCT00902980

    Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

    Astellas Pharma Inc 264 participants Est. completion 2006-12 13 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00905515

    Optima: Optimizing Prograf Therapy in Maintenance Allografts II

    Not yet reported East Carolina University 63 participants Est. completion 2008-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00922883

    A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 43 participants Est. completion 2018-04-24 1 site
    Other conditions: Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT00929695

    Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease

    Not yet reported Fred Hutchinson Cancer Center 164 participants Est. completion 2015-12-14 1 site
    Other conditions: Graft Versus Host Disease, Recurrent Adult Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00946790

    To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

    Not yet reported Sandoz 72 participants Est. completion 1993-12
    Other conditions: Immunosuppression, Rheumatism
    View official trial listing →
  • Completed NCT NCT00968162

    Sickle Cell Disease Conditioning for Bone Marrow Transplant

    Not yet reported Emory University 8 participants Est. completion 2016-01-11 10 sites
    Other conditions: Bone Marrow Transplantation, Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT00972660

    Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease

    Not yet reported Guangdong Provincial People's Hospital 52 participants Est. completion 2017-12 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00987831

    Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

    Not yet reported, Not yet reported Oklahoma Medical Research Foundation 158 participants Est. completion 2012-12 2 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00995709

    Phase III Study in Refractory Behcet's Disease

    Not yet reported Novartis Pharmaceuticals 118 participants Est. completion 2010-07 49 sites
    Other conditions: Behcet Disease
    View official trial listing →
  • Withdrawn NCT NCT01033500

    Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients

    Not yet reported University of Wisconsin, Madison Est. completion 2012-12 1 site
    Other conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT01034345

    Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients

    Not yet reported Hospital Clinic of Barcelona 52 participants Est. completion 2011-11 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01053221

    Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation

    Not yet reported University of Wisconsin, Madison 16 participants Est. completion 2012-08 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01065285

    Vaccination Against Influenza in Autoimmune Diseases

    Not yet reported Assistance Publique - Hôpitaux de Paris 234 participants Est. completion 2012-02 1 site
    Other conditions: Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT01079143

    Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2012-06 23 sites
    Other conditions: Renal Interstitial Fibrosis
    View official trial listing →
  • Status unknown NCT NCT01109498

    Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]

    Not yet reported, Not yet reported Amsterdam Molecular Therapeutics 14 participants Est. completion 2013-06 1 site
    Other conditions: Familial Lipoprotein Lipase Deficiency
    View official trial listing →
  • Completed NCT NCT01135641

    Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)

    Not yet reported Nantes University Hospital 25 participants Est. completion 2014-03 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT01183247

    An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

    Not yet reported University Hospital, Basel, Switzerland 63 participants Est. completion 2010-06 1 site
    Other conditions: Comparative Study, Immunosuppressive Agents
    View official trial listing →
  • Completed NCT NCT01183403

    CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease

    Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 80 participants Est. completion 2012-07 18 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01195194

    Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.

    Not yet reported Josep M Grinyo 61 participants Est. completion 2013-06 2 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01196091

    A Study of LY2127399 in Participants With Systemic Lupus Erythematosus

    Not yet reported Eli Lilly and Company 1164 participants Est. completion 2015-06 192 sites
    Other conditions: Systemic Lupus Erythematosus, Connective Tissue Disease, Autoimmune Disease
    View official trial listing →
  • Status unknown NCT NCT01198314

    Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients

    Not yet reported The Catholic University of Korea 20 participants Est. completion 2013-03 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01213394

    Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients

    Not yet reported Ramesh Prasad 2 participants Est. completion 2011-12 1 site
    Cardiovascular disease Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01220297

    Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

    Not yet reported Stanford University 3 participants Est. completion 2011-08 1 site
    Other conditions: Hematologic Diseases, Acute-graft-versus-host Disease, Leukemia, Non-Hodgkin Lymphoma (NHL), Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01231841

    Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia

    Not yet reported The Cleveland Clinic 20 participants Est. completion 2010-12 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Withdrawn NCT NCT01244659

    A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment

    Not yet reported EMS Est. completion 2014-12 1 site
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01264315

    Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant

    Not yet reported Fondazione EMN Italy Onlus 53 participants Est. completion 2023-02 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01266148

    SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

    Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2012-12 6 sites
    Other conditions: Renal Function and Chronic Allograft Vasculopathy
    View official trial listing →
  • Withdrawn NCT NCT01284257

    Observational Registry Study of Renal Transplant Patients

    Novartis Pharmaceuticals Est. completion 2010-05 8 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01284725

    Weaning of Immunosuppression in Nephritis of Lupus

    Not yet reported Assistance Publique Hopitaux De Marseille 100 participants Est. completion 2018-12-31 1 site
    Other conditions: Nephritis of Lupus
    View official trial listing →
  • Terminated NCT NCT01296061

    Kidney Transplant Failure

    Ottawa Hospital Research Institute 270 participants Est. completion 2017-07 1 site
    Other conditions: Acute Graft Rejection, Renal Failure Chronic Requiring Dialysis
    View official trial listing →
  • Completed NCT NCT01297972

    Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia

    Not yet reported, Not yet reported University of Sao Paulo 9 participants Est. completion 2013-11 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01298492

    A Study To Monitor Long-Term Treatment With PF-00547659

    Not yet reported Shire 268 participants Est. completion 2016-07-27 112 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01300416

    Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

    Novartis Pharmaceuticals 101 participants Est. completion 2012-07 9 sites
    Other conditions: Kidney Transplantation, GI Symptoms Severity
    View official trial listing →
  • Completed NCT NCT01304836

    A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids

    Not yet reported Astellas Pharma Inc 1166 participants Est. completion 2013-05-22 100 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01332201

    Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

    Not yet reported Astellas Pharma Inc 17 participants Est. completion 2013-11 8 sites
    Other conditions: Heart Transplantation, Lung Transplantation, Pancreas (Including SPK) Transplantation
    View official trial listing →
  • Status unknown NCT NCT01332526

    FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).

    Collegium Medicum w Bydgoszczy 70 participants
    Chronic kidney diseaseMetabolic syndrome Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01339468

    A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation

    Not yet reported Astellas Pharma Inc 100 participants Est. completion 2014-05-27 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01342016

    A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients

    Not yet reported Astellas Pharma Inc 84 participants Est. completion 2013-05 12 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01343953

    Cord Blood Transplantation in Severe Aplastic Anemia

    Not yet reported Assistance Publique - Hôpitaux de Paris 26 participants Est. completion 2017-06 1 site
    Other conditions: Hereditary Diseases, Acquired Aplastic Anemia, Relapse, Absence of an HLA Identical Donor
    View official trial listing →
  • Completed NCT NCT01370824

    Clinical Diagnosis of Basal Cell Carcinoma Subtype

    Maastricht University Medical Center 150 participants Est. completion 2013-02 2 sites
    Other conditions: Basal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01404325

    Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 130 participants Est. completion 2017-01-05 9 sites
    Other conditions: Lung Transplantation
    View official trial listing →
  • Status unknown NCT NCT01423552

    Pharmacology of Immunosuppressants Following Heart Transplantation

    Nigel E. Drury 100 participants 2 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Terminated NCT NCT01424345

    The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient

    Not yet reported CAMC Health System 4 participants Est. completion 2012-07 1 site
    Other conditions: Kidney Transplant Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT01428973

    Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

    Not yet reported University of Liege 200 participants Est. completion 2024-12 13 sites
    Other conditions: Graft-Versus-Host Disease, Hematological Malignancies
    View official trial listing →
  • Terminated NCT NCT01446211

    Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis

    Not yet reported Nordic Pharma SAS 4 participants Est. completion 2015-01 1 site
    Other conditions: Wegeners Granulomatosis
    View official trial listing →
  • Terminated NCT NCT01467505

    An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients

    Not yet reported Vertex Pharmaceuticals Incorporated 61 participants Est. completion 2014-04 22 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01467986

    Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma

    Not yet reported University of Regensburg 130 participants Est. completion 2020-09-30 1 site Stand-alone
    Other conditions: Neuroblastoma Recurrent
    View official trial listing →
  • Completed NCT NCT01479881

    A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus

    Not yet reported Tibotec Pharmaceuticals, Ireland 29 participants Est. completion 2011-12 1 site
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT01484496

    A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)

    Not yet reported Human Genome Sciences Inc., a GSK Company 839 participants Est. completion 2015-10-01 207 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01507103

    Tecemotide (L-BLP25) in Rectal Cancer

    Not yet reported Merck KGaA, Darmstadt, Germany 124 participants Est. completion 2014-06 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01508468

    Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

    Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2016-08-31 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Terminated NCT NCT01517984

    Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 52 participants Est. completion 2015-05 11 sites
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01526889

    Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

    Not yet reported Novartis Pharmaceuticals 25 participants Est. completion 2017-08-24 8 sites
    Other conditions: Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious Panuveitis
    View official trial listing →
  • Terminated NCT NCT01561404

    Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise

    Not yet reported Josep M Cruzado 3 participants Est. completion 2013-12 1 site
    Other conditions: Disorder Related to Renal Transplantation, Exercise, Aerobic, Muscle Strength
    View official trial listing →
  • Terminated NCT NCT01562951

    Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

    Not yet reported Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 15 participants Est. completion 2014-03 30 sites
    Obstructive sleep apnea Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01598987

    Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.

    Not yet reported Novartis Pharmaceuticals 56 participants Est. completion 2016-06 32 sites
    Other conditions: Renal Function, Liver Transplant
    View official trial listing →
  • Completed NCT NCT01614665

    A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

    Not yet reported Astellas Pharma Europe Ltd. 44 participants Est. completion 2021-04-21 10 sites
    Other conditions: Heart Transplantation, Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT01631058

    Renal Transplantation in the Elderly - nEverOld Study

    Not yet reported University of Sao Paulo General Hospital 90 participants Est. completion 2019-06 2 sites
    Other conditions: Chronic Renal Failure (CRF), Graft Failure, Transplant; Failure, Kidney, Renal Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT01636466

    The Everolimus-Transplant Exit Strategy Trial (E-TEST)

    Not yet reported Ashtar Chami 1 participants Est. completion 2014-05 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT01640743

    Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 58 participants Est. completion 2014-04 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT01649388

    A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

    Not yet reported Talaris Therapeutics Inc. Est. completion 2023-02-28 3 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01660607

    Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

    Not yet reported, Not yet reported Stanford University 68 participants Est. completion 2023-12-20 1 site
    Other conditions: Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS), Lymphoma, Non-Hodgkin, Acute Lymphoblastic Leukemia (ALL), Myeloproliferative Syndrome, Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT01672957

    An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil

    Hoffmann-La Roche 128 participants Est. completion 2015-07 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01675947

    Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy

    Not yet reported National Eye Institute (NEI) 52 participants Est. completion 2016-02 13 sites
    Other conditions: Geographic Atrophy
    View official trial listing →
  • Completed NCT NCT01678937

    Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents

    Northwestern University 31 participants Est. completion 2008-09 1 site
    Other conditions: Liver Transplant Rejection, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01687192

    Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

    Not yet reported University Hospital, Bordeaux 37 participants Est. completion 2016-10-20 9 sites
    Other conditions: Transplantation, Systemic Lupus Erythematosus, Systemic Immune Disease
    View official trial listing →
  • Completed NCT NCT01695668

    Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%

    Not yet reported University of Michigan 75 participants Est. completion 2015-02
    Other conditions: Dry Eyes
    View official trial listing →
  • Suspended NCT NCT01705899

    Islet Allotransplantation in Type 1 Diabetes

    Not yet reported Ohio State University 20 participants Est. completion 2033-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01705977

    Belimumab Assessment of Safety in SLE

    Not yet reported GlaxoSmithKline 4019 participants Est. completion 2022-08-10 250 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01707849

    The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

    Not yet reported Hospital Vall d'Hebron 18 participants Est. completion 2016-08 1 site
    Other conditions: Hepatitis C Recurrence After Liver Transplant
    View official trial listing →
  • Completed NCT NCT01743560

    An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis

    Not yet reported Novartis Pharmaceuticals 52 participants Est. completion 2016-08-15 11 sites
    Other conditions: Oestrogen Receptor Positive Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01744470

    Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

    Not yet reported University Hospital, Tours 286 participants Est. completion 2015-03 16 sites
    Other conditions: De Novo Transplant Disease
    View official trial listing →
  • Withdrawn NCT NCT01752790

    Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease

    Not yet reported University of Roma La Sapienza Est. completion 2015-12 1 site Stand-alone
    Other conditions: Pediatric Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT01765842

    Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy

    Not yet reported Fundación Pública Andaluza Progreso y Salud 9 participants Est. completion 2015-12 3 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01771809

    Long-Term Safety Of PF-00547659 In Ulcerative Colitis

    Not yet reported Shire 330 participants Est. completion 2017-12-13 99 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT01799460

    Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy

    Shanghai University of Traditional Chinese Medicine 80 participants Est. completion 2013-08 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT01802268

    Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

    Not yet reported Helio Tedesco Silva Junior 320 participants Est. completion 2012-10 6 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01813617

    Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis

    Karolinska University Hospital 72 participants 1 site
    Other conditions: Polymyositis, Dermatomyositis
    View official trial listing →
  • Completed NCT NCT01817504

    Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure

    Not yet reported Hospices Civils de Lyon 56 participants Est. completion 2021-11 9 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT01858259

    Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis

    Gabriela Riemekasten 1372 participants Est. completion 2016-06 11 sites
    Other conditions: Systemic Sclerosis, Interstitial Lung Diseases
    View official trial listing →
  • Completed NCT NCT01860170

    Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

    Not yet reported, Not yet reported Corewell Health West 28 participants Est. completion 2018-03 1 site
    Other conditions: Hematological Malignancy
    View official trial listing →
  • Status unknown NCT NCT01877746

    CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)

    Not yet reported St. Anne's University Hospital Brno, Czech Republic 234 participants Est. completion 2015-09 2 sites
    Other conditions: Inflammatory Cardiomyopathy
    View official trial listing →
  • Terminated NCT NCT01878786

    A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys

    Not yet reported, Not yet reported Matthew Cooper 25 participants Est. completion 2017-12 1 site
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Status unknown NCT NCT01881802

    Study of Opioid Immunosuppressive Effects

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50 participants
    Other conditions: Opioid Abuse or Dependence
    View official trial listing →
  • Terminated NCT NCT01889992

    Cardiac Allograft Remodeling and Effects of Sirolimus

    Not yet reported University of Nebraska 42 participants Est. completion 2018-09-27 1 site
    Other conditions: Cardiac Hypertrophy, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01895049

    Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

    Not yet reported Helio Tedesco Silva Junior 171 participants Est. completion 2017-03-07 1 site
    Other conditions: Kidney Transplantation, Cytomegalovirus
    View official trial listing →
  • Completed NCT NCT01895894

    Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome

    Not yet reported Seoul National University Hospital 34 participants Est. completion 2016-12 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT01901471

    Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock

    Not yet reported Hospices Civils de Lyon Est. completion 2015-10 18 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01903473

    Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

    Not yet reported University of Liege 19 participants Est. completion 2022-09-12 2 sites
    Other conditions: Chronic Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Steroid Refractory Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT01903798

    A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis

    Not yet reported Southern California Institute for Research and Education 4 participants Est. completion 2016-04 3 sites
    Other conditions: Alcoholic Hepatitis
    View official trial listing →
  • Status unknown NCT NCT01905514

    ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients

    Not yet reported Seoul National University Hospital 140 participants Est. completion 2019-12-31 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01908283

    Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease

    Not yet reported Klara M. Pósfay Barbe 300 participants Est. completion 2016-12 1 site
    Other conditions: Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
    View official trial listing →
  • Active, not recruiting NCT NCT01909245

    Islet Cell Transplant for Type 1 Diabetes

    Not yet reported City of Hope Medical Center 10 participants Est. completion 2027-08-31 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01909492

    Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

    Providence Health & Services 30 participants Est. completion 2023-10-05 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT01913392

    Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate

    Maisonneuve-Rosemont Hospital 15 participants Est. completion 2018-05 1 site
    Other conditions: Obesity, Morbid, Transplant; Failure, Kidney
    View official trial listing →
  • Completed NCT NCT01914770

    Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

    GlaxoSmithKline 1016 participants Est. completion 2010-11
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01938625

    A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

    Not yet reported Janssen R&D Ireland 35 participants Est. completion 2015-07-28 6 sites
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Status unknown NCT NCT01959308

    Adherence to Immunosuppressive Therapy Liver Transplant Recipients

    National University Hospital, Singapore 100 participants Est. completion 2014-06 1 site
    Other conditions: Focus : To Study the Differences in Patient Compliance to Immunosuppressive Treatments and Patient Preference.
    View official trial listing →
  • Status unknown NCT NCT01974674

    Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes

    Not yet reported Assistance Publique - Hôpitaux de Paris 19 participants Est. completion 2022-01 1 site
    Other conditions: Patients With Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT01997372

    Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia

    Not yet reported Chinese Academy of Medical Sciences 100 participants Est. completion 2015-11 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02049476

    Study of the Effectiveness of Ozurdex for the Control of Uveitis

    Not yet reported Johns Hopkins University 20 participants Est. completion 2018-06-30 1 site
    Other conditions: Uveitis, Intermediate, Uveitis, Posterior
    View official trial listing →
  • Withdrawn NCT NCT02062892

    Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients

    Not yet reported University of Colorado, Denver Est. completion 2014-06
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02062944

    SRL (Sirolimus) Withdrawal

    Not yet reported Northwestern University 21 participants Est. completion 2020-07 1 site
    Other conditions: Acute Rejection of Liver Transplant, Effects of Immunosuppressant Therapy
    View official trial listing →
  • Completed NCT NCT02066935

    Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil Multicenter Study

    Fundação Instituto Mineiro de Estudo Pesquisa Em Nefrologi 1105 participants Est. completion 2017-09-30 1 site
    Other conditions: Medication Adherence
    View official trial listing →
  • Enrolling by invitation NCT NCT02081755

    Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

    Not yet reported Baylor Research Institute 336 participants Est. completion 2027-03 9 sites
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Completed NCT NCT02083991

    Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

    Not yet reported Vastra Gotaland Region 224 participants Est. completion 2017-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02091973

    MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation

    Not yet reported Chulalongkorn University 50 participants Est. completion 2015-12 1 site
    Other conditions: microRNA Profiles
    View official trial listing →
  • Completed NCT NCT02094417

    A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia

    Not yet reported Kyowa Kirin Korea Co., Ltd. 35 participants Est. completion 2017-11-07 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02103049

    The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients

    Not yet reported University Medical Centre Ljubljana 80 participants Est. completion 2015-12 1 site
    Other conditions: Dyslipidemia, Transplants
    View official trial listing →
  • Terminated NCT NCT02128503

    Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease

    Not yet reported Chinese University of Hong Kong 430 participants Est. completion 2015-10-16 1 site
    Other conditions: Inflammatory Bowel Disease, Crohn Disease, Ulcerative Colitis, Rheumatic Diseases, Hepatitis B, Chronic
    View official trial listing →
  • Active, not recruiting NCT NCT02130362

    A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

    AbbVie 1446 participants Est. completion 2030-11 148 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02130414

    PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects

    Not yet reported Sigmoid Pharma 48 participants Est. completion 2015-02
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02152345

    Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

    Not yet reported Columbia University 57 participants Est. completion 2016-12-31 1 site
    Other conditions: Implant or Graft; Rejection
    View official trial listing →
  • Completed NCT NCT02160054

    Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

    Astellas Pharma Inc 289 participants Est. completion 2016-03-31 30 sites
    Other conditions: the Maintenance Phase After Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02182986

    Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

    National Institute of Allergy and Infectious Diseases (NIAID) 944 participants Est. completion 2019-05-15 7 sites
    Other conditions: Heart Transplant, Small Intestine Transplant, Kidney Transplant, Liver Transplant, EBV-Related PTLD, PTLDs
    View official trial listing →
  • Completed NCT NCT02186275

    The Vitamin D in Pediatric Crohn's Disease

    Not yet reported St. Justine's Hospital 25 participants Est. completion 2019-12-20 10 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02199145

    Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy

    Not yet reported Centre Hospitalier Universitaire de Nice 52 participants Est. completion 2020-06-04 3 sites
    Other conditions: Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT02203396

    A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 40 participants Est. completion 2017-09 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02213068

    Belatacept 3 Month Post Transplant Conversion Study

    Not yet reported Lorenzo Gallon 28 participants Est. completion 2020-09 1 site
    Other conditions: Transplant; Failure, Kidney, EBV
    View official trial listing →
  • Completed NCT NCT02221583

    Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy

    Not yet reported University of Cincinnati 26 participants Est. completion 2015-02 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT02240888

    Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

    Not yet reported Region Skane 300 participants Est. completion 2018-05-31 1 site
    Other conditions: RA, SLE, Vasculitis, Scleroderma, Sjögrens, Syndrome
    View official trial listing →
  • Terminated NCT NCT02255227

    Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 104 participants Est. completion 2022-07-06 8 sites
    Other conditions: Infections, Pneumococcal, Bowel Diseases, Inflammatory
    View official trial listing →
  • Terminated NCT NCT02268201

    A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule

    Not yet reported Astellas Pharma China, Inc. 17 participants Est. completion 2015-03-31 7 sites
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT02270957

    Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches

    Not yet reported Oklahoma Medical Research Foundation 66 participants Est. completion 2021-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02280902

    Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases

    University Hospital, Bordeaux 72 participants Est. completion 2021-11-19 7 sites
    Other conditions: Immunologic and Inflammatory Diseases
    View official trial listing →
  • Terminated NCT NCT02282514

    Stem Cell Transplantation for Stiff Person Syndrome (SPS)

    Not yet reported, Not yet reported Northwestern University 23 participants Est. completion 2019-08-30 1 site
    Other conditions: Stiff-Person Syndrome
    View official trial listing →
  • Completed NCT NCT02286609

    A Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort Pharmacokinetics

    Not yet reported PTC Therapeutics 16 participants Est. completion 2015-02 2 sites
    Other conditions: Hepatic Impairment
    View official trial listing →
  • Completed NCT NCT02286635

    Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort

    Not yet reported PTC Therapeutics 58 participants Est. completion 2014-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT02287311

    Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

    Not yet reported Baylor College of Medicine 38 participants Est. completion 2029-03 2 sites
    Other conditions: Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus, T/NK-lymphoproliferative Disease, Nasopharyngeal Carcinoma, Smooth Muscle Tumor
    View official trial listing →
  • Completed NCT NCT02294032

    The Role of B Cells in Kidney Allograft Dysfunction

    Loma Linda University 180 participants Est. completion 2023-04-24 1 site
    Other conditions: Kidney; Complications, Allograft, Transplantation Infection
    View official trial listing →
  • Completed NCT NCT02294552

    Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

    Not yet reported Ivan S Moiseev 200 participants Est. completion 2017-11 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Lymphoma, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Immune System Diseases
    View official trial listing →
  • Completed NCT NCT02307643

    Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients

    Not yet reported Tanabe Pharma Corporation 17 participants Est. completion 2017-05 14 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02328963

    Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

    Not yet reported University Hospital, Bordeaux 186 participants Est. completion 2018-10-10 9 sites
    Other conditions: Transplantation Infection, Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT02329808

    Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics

    Radboud University Medical Center 93 participants Est. completion 2021-12-03 1 site
    Other conditions: Hematologic Diseases, Oncology Problem, Kidney Diseases, Transplantation Infection
    View official trial listing →
  • Status unknown NCT NCT02342028

    The Number and Function of Regular T Cell in Patients With Obstructive Sleep Apnea

    Taipei Veterans General Hospital, Taiwan 80 participants Est. completion 2015-12 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02347371

    Heart Transplant Registry of Városmajor

    Semmelweis University Heart and Vascular Center 11 participants Est. completion 2020-05 1 site
    Other conditions: Disorder Related to Cardiac Transplantation
    View official trial listing →
  • Status unknown NCT NCT02356445

    Use of Immunosuppressive Therapy for Sarcoidosis

    University of Cincinnati 2000 participants Est. completion 2018-12 1 site
    Other conditions: Sarcoidosis
    View official trial listing →
  • Status unknown NCT NCT02388802

    Human Clinical Trial of Uterine Transplantation in the United Kingdom

    Not yet reported Womb Transplant UK 10 participants Est. completion 2020-01 Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02409576

    Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas

    Not yet reported, Not yet reported National University Hospital, Singapore 20 participants Est. completion 2020-09 1 site
    Obstructive sleep apnea Other conditions: Ewing Sarcoma
    View official trial listing →
  • Completed NCT NCT02444429

    3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation

    Not yet reported Hospices Civils de Lyon 346 participants Est. completion 2024-06-21 8 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT02523768

    Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 117 participants Est. completion 2020-02-24 15 sites
    Other conditions: Glomerulonephritis, IgAN
    View official trial listing →
  • Terminated NCT NCT02531308

    Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)

    Not yet reported Rush University Medical Center 5 participants Est. completion 2016-07 1 site
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02554578

    Impact of mHealth in Heart Transplant Management

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 158 participants
    Other conditions: Heart Transplant
    View official trial listing →
  • Terminated NCT NCT02584647

    PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

    Not yet reported, Not yet reported Gulam Manji 39 participants Est. completion 2024-10-01 5 sites
    Other conditions: Sarcoma, Malignant Peripheral Nerve Sheath Tumors
    View official trial listing →
  • Completed NCT NCT02646657

    An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis

    Not yet reported Geert D'Haens 120 participants Est. completion 2020-08 20 sites
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Status unknown NCT NCT02682459

    ACE-inhibitors in Extracapillary Glomerulonephritis

    Not yet reported Monia Lorini 22 participants Est. completion 2019-12 2 sites
    Other conditions: Extracapillary Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT02684734

    Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis

    University of British Columbia 50 participants Est. completion 2019-12 1 site
    Other conditions: Ulcerative Colitis, Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT02707822

    The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration

    National Taiwan University Hospital 440 participants Est. completion 2018-12 1 site
    Other conditions: Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02711826

    Treg Therapy in Subclinical Inflammation in Kidney Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2023-08-04 6 sites
    Other conditions: Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant, Living Kidney Donor
    View official trial listing →
  • Terminated NCT NCT02723786

    Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation

    Not yet reported GlaxoSmithKline 7 participants Est. completion 2018-03-06 4 sites
    Other conditions: Kidney Transplantation (Status Post)
    View official trial listing →
  • Completed NCT NCT02745717

    The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2021-12 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT02799316

    Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?

    Not yet reported Sherief Abd-Elsalam 100 participants Est. completion 2018-01 1 site
    Other conditions: Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT02839941

    Iguratimod in Kidney Transplant Recipients

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 60 participants Est. completion 2019-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02845596

    Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

    Not yet reported Michael Pulsipher 40 participants Est. completion 2023-07-19 13 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT02877212

    Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

    Not yet reported National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75 participants Est. completion 2017-09 1 site
    Other conditions: Immune Thrombocytopenic Purpura (ITP)
    View official trial listing →
  • Completed NCT NCT02877628

    Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation

    Rennes University Hospital 110 participants Est. completion 2018-12 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02878603

    Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

    Not yet reported Sanofi 104 participants Est. completion 2020-10-23 45 sites Stand-alone
    Other conditions: Acquired Thrombotic Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT02885610

    Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

    Not yet reported RemeGen Co., Ltd. 249 participants Est. completion 2019-07-09 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02917577

    Hepatitis A Vaccine Dosing Regimens Among Pediatric Patients on Immunosuppressive Therapy

    Not yet reported University of Calgary 19 participants Est. completion 2023-06 1 site
    Other conditions: Autoimmune Rheumatologic Disease
    View official trial listing →
  • Terminated NCT NCT02963103

    A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

    Not yet reported Astellas Pharma Korea, Inc. 13 participants Est. completion 2012-10 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT03009565

    Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?

    Rabin Medical Center 800 participants Est. completion 2019-01
    Other conditions: Coronary (Artery) Disease
    View official trial listing →
  • Completed NCT NCT03056924

    Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab

    Boston Medical Center 173 participants Est. completion 2019-01-15 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03079089

    Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

    Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 40 participants Est. completion 2023-09-11 1 site
    Other conditions: Refractory or Relapsed Lymphoid Haemopathy
    View official trial listing →
  • Completed NCT NCT03125772

    Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics

    Not yet reported Fortis Escorts Heart Institute 1830 participants Est. completion 2016-05 1 site
    Type 2 diabetes Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT03136588

    Information and Communication Technology (ICT) Based Centralized Clinical Trial Monitoring System for Drug Adherence

    Not yet reported Kyungpook National University Hospital 114 participants Est. completion 2018-12-31 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Suspended NCT NCT03139747

    UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

    Not yet reported Thomas Jefferson University 5 participants Est. completion 2022-05-30 1 site
    Other conditions: Thyroid Cancer
    View official trial listing →
  • Completed NCT NCT03147183

    Kinetic Study of CD8+ CMV-specific Cellular Immunity in Renal Transplant Patients After Receiving Thymoglobulin

    Maimónides Biomedical Research Institute of Córdoba 150 participants Est. completion 2019-10-21 1 site
    Other conditions: Renal Transplant Infection
    View official trial listing →
  • Completed NCT NCT03161886

    A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).

    Not yet reported Azienda Policlinico Umberto I 48 participants Est. completion 2017-01-10 Stand-alone
    Other conditions: Inflammatory Bowel Diseases, Children, Only
    View official trial listing →
  • Suspended NCT NCT03193073

    Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient

    Not yet reported Omnia Mohammed Hashem 80 participants Est. completion 2020-12-01 1 site
    Chronic kidney disease Other conditions: Endothelial Dysfunction, Left Ventricular Hypertrophy, Fibroblast Growth Factor 23
    View official trial listing →
  • Status unknown NCT NCT03216447

    A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

    Not yet reported Chang Gung Memorial Hospital 150 participants Est. completion 2025-09-30 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT03232268

    HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies

    Not yet reported Institut Paoli-Calmettes 25 participants Est. completion 2026-01-07 1 site
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Active, not recruiting NCT NCT03249831

    A Blood Stem Cell Transplant for Sickle Cell Disease

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2027-01-25 1 site
    Other conditions: Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies, Thalassemia, Anemia, Sickle Cell
    View official trial listing →
  • Completed NCT NCT03304626

    Budesonide for Liver Transplant Immune Suppression

    Not yet reported University of Cincinnati 40 participants Est. completion 2019-12-31 1 site
    Other conditions: Acute Cellular Graft Rejection, New Onset Diabetes After Transplant
    View official trial listing →
  • Completed NCT NCT03349450

    DPX-Survivac and Checkpoint Inhibitor in DLBCL

    Not yet reported Sunnybrook Health Sciences Centre 25 participants Est. completion 2023-07-18 6 sites
    Other conditions: Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03368105

    Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain

    Not yet reported Medical University of Silesia 300 participants Est. completion 2021-07-01
    Other conditions: Clostridium Difficile
    View official trial listing →
  • Status unknown NCT NCT03408210

    Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia

    Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 191 participants Est. completion 2022-08 1 site
    Other conditions: Myelodysplastic Syndromes, Acute Leukemia
    View official trial listing →
  • Status unknown NCT NCT03408223

    Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia

    Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 100 participants Est. completion 2022-12 1 site
    Other conditions: Acute Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT03414658

    The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer

    Not yet reported Adrienne G. Waks 100 participants Est. completion 2027-05-31 17 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03454932

    Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases

    Bone Therapeutics S.A 30 participants Est. completion 2017-06-04
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis
    View official trial listing →
  • Completed NCT NCT03487666

    OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

    Not yet reported Georgetown University 45 participants Est. completion 2024-05-02 4 sites
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03517982

    Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan

    Hikma Pharmaceuticals LLC 12 participants Est. completion 2016-09 1 site
    Other conditions: Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant
    View official trial listing →
  • Completed NCT NCT03530215

    Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)

    Groupe Hospitalier Pitie-Salpetriere 500000 participants Est. completion 2023-04-08 1 site
    Other conditions: Cardiac Disease, Cancer
    View official trial listing →
  • Completed NCT NCT03577431

    Liver Transplantation With Tregs at MGH

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 9 participants Est. completion 2026-02-05 1 site
    Other conditions: Liver Transplant
    View official trial listing →
  • Status unknown NCT NCT03587493

    T-lymphocytes CD8+/HLA-DR+ and Acute Rejection After Lung Transplantation

    Not yet reported Assistance Publique Hopitaux De Marseille 110 participants Est. completion 2022-09 1 site
    Other conditions: Transplant Failure
    View official trial listing →
  • Terminated NCT NCT03591770

    Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

    Not yet reported Boston Medical Center 15 participants Est. completion 2024-07-04 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Withdrawn NCT NCT03605654

    Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

    Not yet reported, Not yet reported Medeor Therapeutics, Inc. Est. completion 2026-10
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT03626714

    Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study

    Not yet reported Auritec Pharmaceuticals 8 participants Est. completion 2019-01-05 1 site
    Other conditions: Organ Transplant Rejection, Psoriasis
    View official trial listing →
  • Status unknown NCT NCT03631563

    ATG-F VS ATG for the Prevention of GVHD

    Not yet reported, Not yet reported Fujian Medical University 120 participants Est. completion 2020-12-01 1 site
    Other conditions: GVHD in the Setting of Haplo-HSCT
    View official trial listing →
  • Completed NCT NCT03657004

    Immunosuppressive Regimen on Changes in Renal Function and Transplant Rejection Rate in Patients With Lung Transplant

    University of Giessen 145 participants Est. completion 2019-08-29 1 site
    Chronic kidney disease Other conditions: Lung Transplant; Complications
    View official trial listing →
  • Status unknown NCT NCT03662087

    HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 100 participants Est. completion 2022-10 1 site
    Other conditions: Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
    View official trial listing →
  • Completed NCT NCT03663335

    Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 418 participants Est. completion 2021-10-29 74 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT03671174

    Immunosuppressant Regimens for Living Fetuses Study

    Not yet reported RenJi Hospital 420 participants Est. completion 2023-02 1 site
    Other conditions: Undifferentiated Connective Tissue Disease, Recurrent Pregnancy Loss
    View official trial listing →
  • Completed NCT NCT03812419

    Esomeprazole or Pantoprazole in Renal Transplantation

    Not yet reported Future University in Egypt 47 participants Est. completion 2016-12-30
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03864796

    Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level

    Assiut University 80 participants Est. completion 2021-01-01 1 site
    Other conditions: Idiopathic Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT03881566

    Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients

    Jongmin Lee 119 participants Est. completion 2020-12-31 1 site
    Other conditions: Sepsis, Immune Deficiency
    View official trial listing →
  • Completed NCT NCT03892317

    Improving Adherence in Nonadherent Kidney Transplant Patients

    Not yet reported Imperial College London 42 participants Est. completion 2020-07-27 1 site
    Other conditions: Medication Adherence, Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT03910452

    Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 4 participants Est. completion 2034-06-15 1 site
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Status unknown NCT NCT03932539

    Improving Immunosuppressive Therapy in Heart Transplantation

    Fondazione IRCCS Policlinico San Matteo di Pavia 25 participants Est. completion 2021-12 4 sites
    Other conditions: Rejection Heart Transplant, Immunosuppression
    View official trial listing →
  • Completed NCT NCT03957694

    Study of AMG531(Romiplostim) in Patients With Aplastic Anemia

    Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 17 participants Est. completion 2021-05-26 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT04013646

    Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

    Not yet reported, Not yet reported Bundang CHA Hospital 24 participants Est. completion 2021-11-02 1 site
    Cardiovascular disease Other conditions: Umbilical Cord Blood, Erythropoietin, Safety, Treatment Outcome
    View official trial listing →
  • Status unknown NCT NCT04020328

    Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

    Not yet reported Shenzhen Second People's Hospital 70 participants Est. completion 2022-05-31 1 site
    Other conditions: Glomerulonephritis, IGA, Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT04023760

    Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients

    Not yet reported University of Saskatchewan 14 participants Est. completion 2020-03-30 1 site
    Other conditions: Pharmacokinetics, Kidney Transplant, Lung Transplant
    View official trial listing →
  • Active, not recruiting NCT NCT04028063

    Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

    Not yet reported University of Colorado, Denver 65 participants Est. completion 2027-12-31 1 site
    Other conditions: Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT04042272

    Evaluation of s100β, NSE and GFAP Levels in Renal Transplantation

    Akdeniz University 80 participants Est. completion 2021-01-15 1 site
    Other conditions: Kidney Transplant; Complications, Neurologic Manifestations, Uremic Encephalopathy
    View official trial listing →
  • Terminated NCT NCT04044560

    Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant

    Not yet reported University of British Columbia 8 participants Est. completion 2022-02-02 3 sites
    Other conditions: B-cell Adult Acute Lymphoblastic Leukemia, Stem Cell Leukemia, Minimal Residual Disease
    View official trial listing →
  • Completed NCT NCT04082416

    Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

    Not yet reported RemeGen Co., Ltd. 335 participants Est. completion 2022-06-30 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT04095936

    Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia

    Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 24 participants Est. completion 2021-10-29 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT04101578

    Clinical Prognosis and Progression of Myasthenia Gravis Patients

    Da, Yuwei, M.D. 2000 participants Est. completion 2024-12-31 1 site
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Status unknown NCT NCT04124861

    Withdraw Drug in Stable IgG4-Related Disease

    Not yet reported Peking Union Medical College Hospital 138 participants Est. completion 2023-06-30 1 site
    Other conditions: Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT04136587

    The Bacterial Secretome in IBD

    Medical University of Graz 74 participants Est. completion 2024-07-31 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Status unknown NCT NCT04152356

    Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

    Guangxi Medical University 50 participants Est. completion 2020-09-01 1 site
    Other conditions: HepatoCellular Carcinoma
    View official trial listing →
  • Completed NCT NCT04233164

    Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 47 participants Est. completion 2022-05-03 1 site
    Other conditions: Systemic Lupus Erythematous (SLE)
    View official trial listing →
  • Completed NCT NCT04259138

    Determination of the Optimal Treatment Target in Ulcerative Colitis

    Not yet reported Alimentiv Inc. 672 participants Est. completion 2026-04-13 58 sites
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Active, not recruiting NCT NCT04262843

    Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia

    Not yet reported City of Hope Medical Center 33 participants Est. completion 2027-05-11 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT04272788

    Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease

    Second Affiliated Hospital of Wenzhou Medical University 32 participants Est. completion 2019-09-29 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT04288271

    Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 96 participants Est. completion 2023-06-30 8 sites
    Other conditions: Medication Adherence, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT04294641

    Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

    Not yet reported National Cancer Institute (NCI) 10 participants Est. completion 2024-10-01 2 sites
    Other conditions: Chronic GVHD
    View official trial listing →
  • Status unknown NCT NCT04295928

    Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients

    Not yet reported University Hospital, Tours 1716 participants Est. completion 2025-09-11 12 sites
    Other conditions: Personalized Pharmaceutical Plan After Transpantation
    View official trial listing →
  • Terminated NCT NCT04305444

    Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

    Not yet reported Zhejiang DTRM Biopharma 55 participants Est. completion 2024-12-31 8 sites
    Other conditions: Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Richter's Transformation
    View official trial listing →
  • Completed NCT NCT04328727

    Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

    Not yet reported Novartis Pharmaceuticals 36 participants Est. completion 2024-12-06 12 sites
    Other conditions: Severe Aplastic Anemia (SAA)
    View official trial listing →
  • Terminated NCT NCT04356404

    Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

    Chinese University of Hong Kong 68 participants Est. completion 2022-01-12 1 site
    Other conditions: Occult Hepatitis B, Biological Substance; Adverse Effect, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT04360031

    The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation

    Université Catholique de Louvain 100 participants Est. completion 2021-03 1 site
    Other conditions: Kidney Transplant; Complications, Immunosuppression, Transplant Failure
    View official trial listing →
  • Status unknown NCT NCT04382781

    Immunosupressive Treatment in COVID-19 Patients

    Spanish Network for Research in Infectious Diseases 500 participants Est. completion 2020-05 1 site
    Other conditions: COVID-19 Infection
    View official trial listing →
  • Completed NCT NCT04420195

    Envarsus XR in Lung Transplant

    Not yet reported NYU Langone Health 41 participants Est. completion 2022-11-30 1 site
    Other conditions: Lung Transplant
    View official trial listing →
  • Terminated NCT NCT04426279

    Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants

    University Hospital, Lille 539 participants Est. completion 2021-08-30 1 site
    Other conditions: Sars-CoV2, Rheumatoid Arthritis, Rheumatic Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT04431245

    Stopping Antiviral Treatment in Chronic Hepatitis B

    The University of Hong Kong 54 participants Est. completion 2026-12-31 1 site
    Other conditions: Chronic Hepatitis b
    View official trial listing →
  • Completed NCT NCT04436367

    Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy

    National Heart, Lung, and Blood Institute (NHLBI) 38 participants Est. completion 2022-03-15 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT04438603

    The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 180 participants Est. completion 2022-09-30 1 site
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT04474392

    Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins

    University of Colorado, Denver 340 participants Est. completion 2026-01-14 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04481633

    Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection

    Not yet reported University Hospital, Toulouse 547 participants Est. completion 2022-12-06 12 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04568421

    Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection

    Sociedad Argentina de Reumatologia 2982 participants Est. completion 2022-12-31 1 site
    Other conditions: Rheumatic Diseases
    View official trial listing →
  • Status unknown NCT NCT04630782

    Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease

    Singapore General Hospital 70 participants Est. completion 2023-01-31 5 sites
    Other conditions: Systemic Sclerosis, Scleroderma
    View official trial listing →
  • Completed NCT NCT04660539

    A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Not yet reported Hoffmann-La Roche 119 participants Est. completion 2024-05-28 53 sites
    Other conditions: Neuromyelitis Optica Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT04672161

    Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients

    Not yet reported Weill Medical College of Cornell University 200 participants Est. completion 2023-06-30 1 site
    Other conditions: Crohn Disease (CD), Ulcerative Colitis (UC), Indeterminate Colitis
    View official trial listing →
  • Completed NCT NCT04688216

    Developing a Risk Assessment System of Multidrug-resistant Organisms Infection

    Second Affiliated Hospital, Zhejiang University, School of Medicine 917 participants Est. completion 2022-12-30 1 site
    Other conditions: Bacterial Infections
    View official trial listing →
  • Status unknown NCT NCT04698213

    Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma

    Not yet reported Consorzio Oncotech 75 participants Est. completion 2024-10 20 sites
    Other conditions: Renal Carcinoma Metastatic
    View official trial listing →
  • Completed NCT NCT04734197

    A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

    Not yet reported Surface Ophthalmics, Inc. 349 participants Est. completion 2022-03-25 40 sites
    Other conditions: Dry Eye Disease
    View official trial listing →
  • Terminated NCT NCT04773392

    Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

    Not yet reported University of Southern California 20 participants Est. completion 2024-02-23 1 site
    Other conditions: Kidney Transplantation, Kidney Transplant Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT04789070

    Phase III Trial of Sirolimus in IBM

    Not yet reported University of Kansas Medical Center 140 participants Est. completion 2027-12 10 sites
    Other conditions: Inclusion Body Myositis
    View official trial listing →
  • Completed NCT NCT04818892

    Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease

    University of Wisconsin, Madison 222 participants Est. completion 2022-11-11 1 site
    Other conditions: IBD, Covid19 Vaccine
    View official trial listing →
  • Completed NCT NCT04848493

    National Project on Vaccines, COVID-19 and Frail Patients

    Azienda USL Reggio Emilia - IRCCS 747 participants Est. completion 2022-12-31 12 sites
    Other conditions: COVID-19, Solid Tumor, Hematologic Diseases, Neurologic Disorder, Rheumatic Diseases
    View official trial listing →
  • Completed NCT NCT04870359

    Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation

    Not yet reported The University of Hong Kong 49 participants Est. completion 2022-03-31 2 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT04870411

    Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics

    Assistance Publique - Hôpitaux de Paris 78 participants Est. completion 2022-03-13 1 site
    Other conditions: Autoimmune Diseases, Inflammatory Disorder
    View official trial listing →
  • Status unknown NCT NCT04883164

    Immunity After COVID-19 Vaccination

    Plexision 300 participants Est. completion 2023-03-31 1 site
    Other conditions: Immunity to COVID-19
    View official trial listing →
  • Status unknown NCT NCT04895423

    Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood

    Not yet reported National Medical Research Center for Children's Health, Russian Federation 160 participants Est. completion 2023-07-25 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT04915482

    TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

    Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 94 participants Est. completion 2025-02-28 1 site
    Other conditions: Immune Thrombocytopenia (ITP), Autoantibodies, Evan Syndrome, Connective Tissue Diseases
    View official trial listing →
  • Terminated NCT NCT04930055

    Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)

    Indiana University 2206 participants Est. completion 2022-03-08 2 sites
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT04942314

    Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective Study

    Jia Deng 600 participants Est. completion 2023-06-01
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT04945889

    Sepsis in Geriatric Patients With Suspected Infection.

    A.O.U. Città della Salute e della Scienza 580 participants Est. completion 2019-10-31 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Status unknown NCT NCT04946669

    An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 20 participants Est. completion 2022-07-31 1 site
    Other conditions: Dermatomyositis, Abatacept
    View official trial listing →
  • Completed NCT NCT04955366

    Abatacept Conversion in Kidney Transplantation

    Not yet reported Emory University 87 participants Est. completion 2026-06-10 1 site
    Other conditions: Renal Transplant Recipient
    View official trial listing →
  • Completed NCT NCT04976933

    Post-HSCT Medication Adherence mHealth App

    Micah Skeens 15 participants Est. completion 2023-01-31 1 site
    Other conditions: Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT04978623

    Role of High Frequency Ultrasound in Demyelinating Polyneuropathies

    Centre Hospitalier Universitaire de Nice 48 participants Est. completion 2022-12-01 1 site
    Other conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
    View official trial listing →
  • Completed NCT NCT05020145

    COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

    Pfizer 1277747 participants Est. completion 2021-12-17 1 site
    Other conditions: Immunocompromised, Immunosuppressed, Covid-19, SARS-COV-2, SARS-COV-2 Infection, Breakthrough Infection
    View official trial listing →
  • Completed NCT NCT05030974

    RECOVAC Repeated Vaccination Study

    Not yet reported University Medical Center Groningen 336 participants Est. completion 2022-03-12 4 sites
    Other conditions: Covid19, Kidney Diseases, Vaccine Response Impaired, SARS-CoV2 Infection
    View official trial listing →
  • Completed NCT NCT05038982

    Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

    Not yet reported Johns Hopkins University 20 participants Est. completion 2022-07-11 1 site
    Other conditions: Prurigo Nodularis, Pruritus, Chronic Pruritus, Chronic Prurigo, Skin Diseases
    View official trial listing →
  • Status unknown NCT NCT05047406

    Bacillus Clausii in Liver Transplantation

    Not yet reported Ain Shams University 60 participants Est. completion 2023-08-30 1 site
    Other conditions: Transplantation Infection, Liver Grafting, Hepatic Transplantation
    View official trial listing →
  • Terminated NCT NCT05078710

    Telitacicept in Primary APS Patients

    Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2025-06-01 1 site
    Other conditions: Anti Phospholipid Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT05089370

    Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

    Not yet reported, Not yet reported University of Colorado, Denver 8 participants Est. completion 2026-10 1 site
    Other conditions: Malignant Melanoma
    View official trial listing →
  • Active, not recruiting NCT NCT05132166

    A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease

    Not yet reported University Health Network, Toronto 50 participants Est. completion 2026-04-26 1 site
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Status unknown NCT NCT05140616

    Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD

    Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 20 participants Est. completion 2024-05-31 1 site
    Other conditions: Safety and Efficacy
    View official trial listing →
  • Status unknown NCT NCT05157750

    Endoscopic Remission, Histologic Remission and Barrier Healing for Predicting Disease Behaviour in IBD

    University of Erlangen-Nürnberg Medical School 180 participants Est. completion 2022-05-01 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • No Longer Available NCT NCT05215288

    Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients

    Direct Biologics, LLC 2 sites
    Other conditions: Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ Rejection
    View official trial listing →
  • Completed NCT NCT05238467

    Immunological Responses of COVID-19 Vaccination

    University Hospitals Cleveland Medical Center 42 participants Est. completion 2023-02-13 1 site
    Other conditions: Cancer; Chemotherapy
    View official trial listing →
  • Status unknown NCT NCT05282875

    Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis

    Central Hospital, Nancy, France 430 participants Est. completion 2022-09-01 1 site
    Other conditions: Kidney Transplantation, Immunosuppressive Agents, HLA Sensitization, Dialysis
    View official trial listing →
  • Active, not recruiting NCT NCT05342519

    Daily Topical Rapamycin for Vitiligo

    Not yet reported Medical University of South Carolina 20 participants Est. completion 2027-12-01 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Active, not recruiting NCT NCT05345197

    Emicizumab in Patients With Acquired Hemophilia A

    Not yet reported University of Washington 51 participants Est. completion 2026-12 16 sites
    Other conditions: Acquired Hemophilia A
    View official trial listing →
  • Not yet recruiting NCT NCT05415579

    Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM)

    Dongzhimen Hospital, Beijing 2000 participants Est. completion 2030-05-31
    Other conditions: Demyelinating Diseases of the Central Nervous System (DDC)
    View official trial listing →
  • Status unknown NCT NCT05415995

    A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases

    Not yet reported Zhejiang Zylox Medical Device Co., Ltd. 202 participants Est. completion 2024-12 20 sites Stand-alone
    Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Completed NCT NCT05452187

    Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study

    Hospital Mutua de Terrassa 79 participants Est. completion 2021-12-20 1 site
    Other conditions: Inflammatory Bowel Diseases, Hepatitis C Virus Infection
    View official trial listing →
  • Status unknown NCT NCT05498740

    Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

    Not yet reported Zhejiang Zylox Medical Device Co., Ltd. 200 participants Est. completion 2024-12 24 sites Stand-alone
    Other conditions: Peripheral Arterial Disease (PAD)
    View official trial listing →
  • Active, not recruiting NCT NCT05537948

    Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 59 participants Est. completion 2025-01-31 1 site
    Other conditions: Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder, Immunosuppression, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Statins
    View official trial listing →
  • Completed NCT NCT05542381

    The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

    Not yet reported Virginia Polytechnic Institute and State University 64 participants Est. completion 2025-05-01 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Terminated NCT NCT05570409

    Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

    Not yet reported, Not yet reported LMU Klinikum 9 participants Est. completion 2025-04-14 14 sites
    Other conditions: Inflammatory Cardiomyopathy
    View official trial listing →
  • Terminated NCT NCT05600426

    A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

    Not yet reported Boston Children's Hospital 53 participants Est. completion 2026-08-06 52 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT05621356

    Monitoring Allergen Immunotherapy in Allergic Rhinitis

    Rijnstate Hospital 25 participants Est. completion 2023-03-31 1 site
    Other conditions: Immunotherapy, Rhinitis, Allergic, Treatment Outcome
    View official trial listing →
  • Active, not recruiting NCT NCT05626387

    An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 144 participants Est. completion 2026-10-23 9 sites
    Other conditions: Hypersensitivity Pneumonitis
    View official trial listing →
  • Active, not recruiting NCT NCT05637112

    A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice.

    AstraZeneca 551 participants Est. completion 2030-12-30 74 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT05696106

    Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID

    Assistance Publique - Hôpitaux de Paris 750000 participants Est. completion 2024-01-15 1 site
    Other conditions: Inflammatory Disease
    View official trial listing →
  • Completed NCT NCT05697809

    Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema

    Not yet reported Oxular Limited 3 participants Est. completion 2024-12-05 9 sites
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT05765955

    Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses

    Not yet reported Poolbeg Pharma plc 36 participants Est. completion 2022-12-16 1 site
    Other conditions: Influenza, Human
    View official trial listing →
  • Status unknown NCT NCT05772871

    The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children

    Not yet reported Jianhua Zhou 402 participants Est. completion 2025-10-30 26 sites
    Other conditions: Nephrotic Syndrome in Children
    View official trial listing →
  • Active, not recruiting NCT NCT05782907

    Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

    Not yet reported AbbVie 122 participants Est. completion 2031-10 89 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT05799755

    Myositis Interstitial Lung Disease Nintedanib Trial

    Not yet reported Rohit Aggarwal, MD 62 participants Est. completion 2025-12-31 10 sites
    Other conditions: Myositis Associated Interstitial Lund Disease (MA-ILD)
    View official trial listing →
  • Completed NCT NCT05816486

    BIOtechnology Applied to Renal TRansplantation With IMmunobiogram

    Biohope Scientific Solutions for Human Health, S.L. 443 participants Est. completion 2024-06-30 15 sites
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Status unknown NCT NCT05848427

    The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19

    Lebanese University 1000 participants Est. completion 2025-12-30 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05852977

    Study of Dengue in Patients With Autoimmune Diseases During the Epidemics of 2020 and 2021 in Reunion Island

    Centre Hospitalier Universitaire de la Réunion 90 participants Est. completion 2026-06
    Other conditions: Dengue
    View official trial listing →
  • Status unknown NCT NCT05863936

    Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

    Not yet reported Nanjing University School of Medicine 15 participants Est. completion 2024-12-31 1 site
    Other conditions: Lupus Nephritis, Remission, Safety Issues
    View official trial listing →
  • Active, not recruiting NCT NCT05873205

    Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

    Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2027-06-29 7 sites
    Other conditions: Blood Cancer, Refractory Immune Cytopenias
    View official trial listing →
  • Completed NCT NCT05874349

    Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease

    Hospital Mutua de Terrassa 200 participants Est. completion 2023-01-01 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05879419

    Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

    Not yet reported University of Sao Paulo General Hospital 2005 participants Est. completion 2032-06-30 1 site
    Other conditions: Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome, Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Vasculitis, Systemic, Juvenile Idiopathic Arthritis, Dermatomyositis, Juvenile, Behçet Disease
    View official trial listing →
  • Withdrawn NCT NCT05881668

    MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University Est. completion 2025-04-30 1 site
    Other conditions: Liver Failure, Acute on Chronic
    View official trial listing →
  • Completed NCT NCT05894512

    Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy

    Istanbul University 44 participants Est. completion 2026-02-15 1 site
    Other conditions: Membranous Nephropathy, Membranous Nephropathy - PLA2R Induced, Membranous Nephropathy - THSD7A Induced
    View official trial listing →
  • Completed NCT NCT05924685

    PREPARE-iVAC Trial

    Not yet reported University Medical Center Groningen 110 participants Est. completion 2024-02-27 7 sites
    Other conditions: COVID-19 Vaccines, Varicella Zoster Vaccine, Vaccine Response, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT05925140

    LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

    Not yet reported Lebanese University 1000 participants Est. completion 2025-12-30 2 sites
    Other conditions: COVID-19, Hospitalized COVID-19 Patients
    View official trial listing →
  • Status unknown NCT NCT05947864

    Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients

    Not yet reported Hospices Civils de Lyon 60 participants Est. completion 2026-07 1 site
    Other conditions: Transplantation, Hematopoietic Stem Cell
    View official trial listing →
  • Completed NCT NCT05995938

    Mindfullnes-Based Cognitive Therapy Effect

    Not yet reported SEMRA BÜLBÜLOĞLU 140 participants Est. completion 2023-01-30 1 site
    Other conditions: Mindfullnes-Based Cognitive Therapy and Adherence to Immunosuppressive Therapy
    View official trial listing →
  • Completed NCT NCT05999955

    Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis

    Not yet reported Huro Biotech Joint Stock Company 60 participants Est. completion 2023-05-25 1 site
    Other conditions: Rhinosinusitis, Rhinitis
    View official trial listing →
  • Status unknown NCT NCT06009965

    Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

    Not yet reported Peking Union Medical College Hospital 210 participants Est. completion 2025-01-31 1 site
    Other conditions: Aplastic Anemia, CSA, Drug Therapy
    View official trial listing →
  • Status unknown NCT NCT06019234

    Juvenile Systemic Sclerosis, a Retrospective Epidemiological Study on a French Cohort

    University Hospital, Strasbourg, France 30 participants Est. completion 2024-10-03 1 site
    Other conditions: Juvenile Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT06026787

    Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

    Not yet reported Ain Shams University 60 participants Est. completion 2023-08-01 1 site
    Other conditions: Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors
    View official trial listing →
  • Completed NCT NCT06046534

    Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

    AstraZeneca 46 participants Est. completion 2024-06-10 15 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT06105658

    Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

    Not yet reported Anhui Provincial Hospital 20 participants Est. completion 2026-02-01 1 site
    Other conditions: Acute Myelocytic Leukemia
    View official trial listing →
  • Not yet recruiting NCT NCT06109961

    Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study

    Not yet reported, Not yet reported University of British Columbia 54 participants Est. completion 2028-03
    Other conditions: Inflammatory Bowel Disease (IBD), Crohn Disease
    View official trial listing →
  • Status unknown NCT NCT06125457

    Epidemiology of IgA Selective Deficiency - Clinical Manifestations and Risk of Transmission

    University Hospital, Strasbourg, France 120 participants Est. completion 2023-12-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Not yet recruiting NCT NCT06150287

    Effect of Probiotics on Immunosuppressive-drug-associated Diarrhea Among Renal Transplant Recipients

    Not yet reported State University of New York - Upstate Medical University 70 participants Est. completion 2027-05
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT06196996

    Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus

    Not yet reported Shanghai Changzheng Hospital 18 participants Est. completion 2026-09 1 site
    Other conditions: Brittle Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT06238336

    Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

    Not yet reported, Not yet reported Shanxi Bethune Hospital 30 participants Est. completion 2025-12-20 1 site
    Other conditions: Hematological Malignancy
    View official trial listing →
  • Active, not recruiting NCT NCT06332534

    Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

    Not yet reported AbbVie 111 participants Est. completion 2031-01 85 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT06368349

    Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma

    Chang Gung Memorial Hospital 190 participants Est. completion 2023-06-30 1 site
    Other conditions: Lymphopenia
    View official trial listing →
  • Withdrawn NCT NCT06461546

    Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients

    Not yet reported Fundacion Clinic per a la Recerca Biomédica Est. completion 2027-05
    Other conditions: Kidney Transplant Candidates
    View official trial listing →
  • Status unknown NCT NCT06504784

    The Role of Gut Bacteria in the Immune Response to Vaccination in Patients With Ulcerative Colitis

    Not yet reported Sahlgrenska University Hospital 150 participants Est. completion 2025-10 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT06613880

    Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 48 participants Est. completion 2026-09-30 1 site
    Other conditions: Aplastic Anemia, TPO Receptor Agonists
    View official trial listing →
  • Completed NCT NCT06637683

    Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)

    Not yet reported Anabio R&D 60 participants Est. completion 2020-06-20 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT06650124

    Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMF

    Not yet reported, Not yet reported Institute of Liver and Biliary Sciences, India 108 participants Est. completion 2025-12-31
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Completed NCT NCT06689098

    Magnetocardiography as a Diagnostic Screening Tool for Myocarditis and Other Types of Cardiomyopathy

    German Heart Institute 330 participants Est. completion 2024-12-01 1 site
    Other conditions: Cardiomyopathies
    View official trial listing →
  • Suspended NCT NCT06694454

    Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

    Not yet reported, Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2034-12-31 1 site
    Other conditions: Non-small Cell Lung Cancer (NSCLC), Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Carcinoma, Non Small Cell Lung Cancer, Non Small Cell Lung Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT06723548

    Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

    Not yet reported First Affiliated Hospital of Wenzhou Medical University 30 participants Est. completion 2026-12
    Other conditions: Myasthenia Gravis, Autoimmune Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT06825572

    MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 30 participants Est. completion 2026-09-30 1 site
    Other conditions: Liver Failure, Mesenchymal Stem Cell, Extracellular Vesicles
    View official trial listing →
  • Not yet recruiting NCT NCT06886646

    Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation

    Not yet reported Assistance Publique - Hôpitaux de Paris 22 participants Est. completion 2029-10-15 1 site
    Other conditions: Chronic Antibody-mediated Rejection (cABMR)
    View official trial listing →
  • Not yet recruiting NCT NCT06942156

    Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

    Not yet reported Chong Kun Dang Pharmaceutical 140 participants Est. completion 2030-12 1 site
    Other conditions: Heart Transplant
    View official trial listing →
  • Not yet recruiting NCT NCT06971172

    Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients.

    Not yet reported Cairo University 22 participants Est. completion 2025-09-01
    Other conditions: Pemphigus Vulgaris
    View official trial listing →
  • Withdrawn NCT NCT07001254

    UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia

    Not yet reported Anjali Sharathkumar Est. completion 2031-12-31 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT07005466

    Bronchoalveolar Lavage Combined With High-throughput Sequencing Technology

    Nanfang Hospital, Southern Medical University 500 participants Est. completion 2024-12-30 1 site
    Other conditions: Pneumonia
    View official trial listing →
  • Active, not recruiting NCT NCT07015983

    A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

    Not yet reported Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89 participants Est. completion 2032-06-15 97 sites
    Other conditions: Lupus Erythematosus, Systemic, Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT07035561

    Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis

    Not yet reported Shereen Medhat Mohammed Elsayed Nassar 30 participants Est. completion 2025-01-31 1 site
    Other conditions: Hypersenstivity Pneumonitis, ILD
    View official trial listing →
  • Completed NCT NCT07089420

    ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

    American Laboratory Products Company 121 participants Est. completion 2026-04-15 1 site
    Other conditions: IBD (Inflammatory Bowel Disease), IBS - Irritable Bowel Syndrome, Crohn Disease (CD), UC - Ulcerative Colitis
    View official trial listing →
  • Not yet recruiting NCT NCT07172945

    Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.

    Not yet reported Assistance Publique - Hôpitaux de Paris 4500 participants Est. completion 2040-11
    Other conditions: Crohn, Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease)
    View official trial listing →
  • Not yet recruiting NCT NCT07203664

    Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

    Not yet reported Hospital Universitario La Paz 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
    View official trial listing →
  • Active, not recruiting NCT NCT07262437

    Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles

    Not yet reported University of Milan 220 participants Est. completion 2026-07-01 3 sites
    Other conditions: Uveitis Posterior Non-Infectious, Inflammation Eye, Uveitis, Uveitis, Anterior
    View official trial listing →
  • Enrolling by invitation NCT NCT07309588

    Hyaluronic Acid in the Treatment of Hyposalivation

    Not yet reported, Not yet reported Poznan University of Medical Sciences 100 participants Est. completion 2026-01-19 1 site
    Other conditions: Xerostomia Due to Hyposecretion of Salivary Gland
    View official trial listing →
  • Not yet recruiting NCT NCT07325357

    Effect of Pirfenidone on TA Fibrosis

    Not yet reported Shanghai Zhongshan Hospital 92 participants Est. completion 2030-12-31
    Other conditions: Takayasu Arteritis
    View official trial listing →
  • Not yet recruiting NCT NCT07338422

    HID-HSCT Versus IST as First-line Treatment for SAA

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 116 participants Est. completion 2030-09-14
    Other conditions: Aplastic Anaemia
    View official trial listing →
  • Not yet recruiting NCT NCT07364123

    Kidney Transplant Immunosuppressive Therapy Adherence Trial (KITE)

    Not yet reported University of Gaziantep 60 participants Est. completion 2026-08-15 1 site
    Other conditions: Kidney Transplantation, Medication Non-Adherence, Immunosuppressive Therapy, Renal Transplant Recipients
    View official trial listing →
  • Not yet recruiting NCT NCT07380659

    Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 18 participants Est. completion 2027-02-28 1 site
    Cardiovascular disease Other conditions: Cardiogenic Shock
    View official trial listing →
  • Completed NCT NCT07430449

    The Effect of Education Given According to Roy's Adaptation Model

    Not yet reported Trakya University 78 participants Est. completion 2025-06-15 1 site
    Chronic kidney disease Other conditions: Immunosuppressive Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07431775

    Saphnelo Use in Females of Child-bearing Potential

    AstraZeneca 26000000 participants Est. completion 2032-03-31
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Active, not recruiting NCT NCT07486206

    Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

    Not yet reported Hospital de Granollers 152 participants Est. completion 2027-09-30 1 site
    Other conditions: Interstitial Lung Disease (ILD), Fibrotic Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis, Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)
    View official trial listing →
  • Not yet recruiting NCT NCT07505576

    Anti-alpha-actinin Antibodies and Lupus Nephritis Activity

    Assiut University 96 participants Est. completion 2027-10-01
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Active, not recruiting NCT NCT07519005

    Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure

    Not yet reported Xijing Hospital 1 participants Est. completion 2026-12-31 1 site
    Other conditions: Hepatic Failure
    View official trial listing →
  • Not yet recruiting NCT NCT07543640

    EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL.

    Not yet reported Eman Raafat Said 56 participants Est. completion 2026-08
    Other conditions: Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital Psoriasis
    View official trial listing →
  • Not yet recruiting NCT NCT07570433

    HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial

    Not yet reported Oriol Manuel 100 participants Est. completion 2028-03 4 sites
    Other conditions: CMV Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07572695

    Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2028-12
    Other conditions: Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/Refractory
    View official trial listing →
  • Not yet recruiting NCT NCT07638709

    Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases

    Xiangya Hospital of Central South University 150 participants Est. completion 2030-06-01 1 site
    Other conditions: Non Small Cell Lung, Brain Metastasases
    View official trial listing →
  • Not yet recruiting NCT NCT07642297

    TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)

    Fondazione Policlinico Universitario Campus Bio-Medico 20 participants Est. completion 2028-09-01 1 site
    Other conditions: Systemic Sclerosis (SSc), Diffuse Cutaneous Systemic Sclerosis, Skin Fibrosis
    View official trial listing →
  • Not yet recruiting NCT NCT07643038

    Treatment Strategy for Patients With RA-ILD

    Not yet reported Chinese SLE Treatment And Research Group 204 participants Est. completion 2029-07-31 22 sites
    Other conditions: Rheumatoid Arthritis Associated Interstitial Lung Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07715565

    Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

    Not yet reported West China Hospital 66 participants Est. completion 2029-12 1 site
    Other conditions: Renal Cell Carcinoma (Kidney Cancer), Immunotherapy, Molecular Targeted Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07718633

    Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)

    Not yet reported Natera, Inc. 750 participants Est. completion 2031-07
    Other conditions: Kidney Transplant, Immunosuppresion
    View official trial listing →
  • Active, not recruiting NCT NCT07773623

    An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory Uveitis

    Not yet reported Tianjin Medical University 30 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT07850362

    Clinical Study of UC-MSC Combined With Immunosuppressive Agents in the Treatment of Pediatric HAAA

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 20 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Hepatitis-associated Aplastic Anemia, Severe Aplastic Anemia(SAA), Umbilical Cord Blood, Mesenchymal Stem Cells, Pediatric
    View official trial listing →
  • Not yet recruiting NCT NCT07859839

    Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 177 participants Est. completion 2027-07-31 1 site
    Other conditions: Interstitial Lung Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07893691

    Microbiota Changes Related to Outcomes in Kidney Transplantation

    Hospices Civils de Lyon 30 participants Est. completion 2029-01-15 1 site
    Other conditions: End-stage Renal Disease (ESRD), Kidney Transplantation
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.